First experience in sharing my article on Twitter😝😝. Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram frontiersin.org/article/10.338…

Our recent work😀HIPEC for gynecologic cancer patients! A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy frontiersin.org/article/10.338…

IJGC Fellows mentor's #podcast w/ Dr. Ignace Vergote Dr. Vergote talks about: ☑️ his career path ☑️ EORTC55971 ☑️ What he looks for in a gynonc fellow & MORE~~ ➡️soundcloud.com/bmjpodcasts/th… Pedro T Ramirez Ane Gerda Z Eriksson MD PhD OncoAlert IGCS GYN Cancer | #GYNCSM ESGO European Network of Young Gynae Oncologists

As usual, today is a busy day. Suspected lymphoma-ovarian metastasis; biopsies of mesenteric lymph nodes+unilateral salpingo-oophorectomy. Primary carcinosarcoma of the ovary. Staging surgery for UPSC with pelvic LN M.

Proud to present our #LESSERtrial published in the IJGC, by IGCS, ESGO & BMJ Group. #gyncancer #gyncsm #LESSER Sociedade Brasileira de Cirurgia Oncológica (SBCO) CBCcirurgioes EVA - Brazilian Gynecologic Oncology Group eLight SGO European Society of Surgical Oncology (ESSO) Mario M. Leitao, Jr Pedro T Ramirez René Pareja Kathleen Schmeler MD 🧶 1/n

Is para-aortic #lymphadenectomy necessary at #radicalhysterectomy for #cervicalcancer? authors.elsevier.com/c/1gX7zKfi8wfU… From Alyssa Mercadel et al. UTSW_ObGyn, UTSW Simmons Cancer Center, UTSW Media Relations, Clements University Hospital, & Parkland Health #cervicalcancerawarenessmonth GYN Cancer | #GYNCSM

Happy to share our new work in HIPEC. Docetaxel, in combination with a fixed dose of cisplatin (75 mg/m2), can be used safely at 75 mg/m2 in OC patients receiving HIPEC.A phase I dose-finding trial of ... J Gynecol Oncol. 2023 Jul;35:e1. doi.org/10.3802/jgo.20…

🎉Just before 2023 comes to a close and I couldn't be more thrilled! My article has just been published online by Gynecologic Oncology! 📚🎊 Immensely grateful to the amazing CRS-HIPEC team at Sun Yat-sen Memorial Hospital! 🙌 doi.org/10.1016/j.ygyn…

≥8 OC surgeries + many more procedures for pts with EC & CC in high volume centers such as Sun Yat-sen Memorial Hospital. OR resource is limiting. Exploring the feasibility of HIPEC in General Wards is highly warranted. GARD-HIPEC is expected to enroll the 1st pts within 3 m!

Absolutely thrilled to be in Nagoya for #JSMO2024!

Two cases we've recently worked on. Vulvar cancer: radical vulvectomy followed by vulvar reconstruction. Recurrent yolk sac tumor: Para-aortic M with AFP 1100. Para-aortic M dis+BEP chemo. Following 1st chemo, AFP neg. #SunYatsenMemorialHospital #GynecologicOncology

In the SHAPE randomized trial in patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy with respect to 3-year pelvic recurrence & was associated with a lower risk of urologic complications. Full trial results: nej.md/4bQqME5

Resection of hepatic hilar metastases is crucial in the surgical treatment of ovarian cancer. #gynecologiconcology #surgery #ovariancancer

En-bloc posterior-pelvic exenteration, diaphragmatic stripping, and omentectomy. Hoping the patient benefits from an R0 resection.#gynecologic #oncology #OvarianCancer

Thrilled to shard that our work just went online in @NatureCommunications.👏👏 Hyperthermia+WEE1 inhibitors👉👉synthetic lethality. Promising implications for OC pts. Excited for upcoming clinical trials💪💪!! #gynecologic #HIPEC #OvarianCancer #WEE1 rdcu.be/dABZG

We should know patients with III-IVA disease benefit from the addition of Pemb. thelancet.com/journals/lance…

Cervical SC carcinoma, clinical stage IB2(FIGO IIIC2 p). Extensive para-aortic lymph node (Max 6cm) metastasis with swollen lymph nodes encircling the aorta and inferior vena cava. All removed.🤩😍😍😍